How is precision medicine making its mark in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Accelerating biotherapy and personalised medicine with long DNA" and "The microbiome in precision medicine".

In the first article, Matt Hill, Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development.

In the second article, Katie Gillette, Senior Project Leader, Eliza French, Analyst, and Graham Friedman, Analyst, DeciBio, provide an industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development.